Brazil Safety Board Rejected Russia’s Sputnik V Vaccine; Inspection Team was Denied Access to Facility that Developed Sputnik V; Safety Board Approved After Russia Threatened to Sue; Russia to Make Over $30 Billion from Sputnik V Vaccine Export over 2 years

Tags

Adenovirus DNA integration into mammalian genomes, adenovirus vector DNA & RNA-based SARS-CoV-2 vaccines, adenovirus vector DNA integration into human genome, Anvisa, Bolsanaro, Brazil, Covid-19 vaccines, defective vaccines, DNA Vaccine, epigenetic consequences of foreign DNA integration, expression of adenoviral genes in vector DNA, HEK293, inspection, Putin, Putin promotes Covid-19 vaccine exports, Putin promotes Covid-19 vaccines, retrotranscription of SARS-CoV-2 RNA into DNA, Russia, Russian invasion Ukraine, Russian threats, Russian vaccine exports, Sputnik V, Sputnik V profits, Sputnik V vaccines, vaccine competition, Vaccine safety, viral vector vaccine

The Sputnik DNA-viral vector vaccine was supposedly developed and, in part, produced by the Russian govt. Thus, any profits could be funding the war in Ukraine. That could explain why those pushing distrust of mRNA vaccines suddenly flipped to supporting Russia’s invasion of Ukraine. Non-Sputnik vaccines are business competitors. Brazil is using a Chinese vaccine, as well as others. Brazil was alarmed about finding living cold viruses in the Sputnik vaccine vials. Nonetheless, Brazil was intimidated into approving Sputnik. Both Bolsonaro and Lula have enjoyed good relations with Putin.

Mining Awareness +

Sputnik V is a DNA (viral vector) vaccine, which underwent little testing, and which uses the embryonic cell line HEK293 in its production. Furthermore, DNA vaccines are at least as risky as mRNA vaccines, and maybe more so. Putin promoted Covid-19 testing and vaccines and vaccine export, especially to Africa, during the 2021 World Economic Forum.

The estimated $30 billion made from vaccine exports is only for Sputnik V. Russia has some other vaccines, as well: “the Russian Direct Investment Fund (RDIF), together with the Gamaleya Center, which developed the Sputnik vaccine, announced that Sputnik would be sold to foreign partners at a price of at least $20 per set. As of April 2021, it was known that Sputnik V was approved for use in 60 countries with a total population of over one and a half billion people. Experts believe that manufacturers will earn more than $ 30…

View original post 2,337 more words